Semax

Semax is a synthetic peptide derived from the ACTH(4–10) fragment of adrenocorticotropic hormone, modified to enhance stability and biological resistance during research use.

It is commonly investigated for its potential interaction with:

• Cognitive-performance and focus-related pathways
• Neuroprotective and neuroplasticity signaling
• Brain-derived neurotrophic factor (BDNF) pathways
• Dopaminergic and monoamine-related signaling
• Memory and learning-associated pathways
• Stress-response and neuroendocrine regulation

Unlike traditional stimulant-based compounds, Semax is researched for its broader neurotrophic and neuromodulatory research profile involving cognitive-performance and neuroplasticity-related pathways.

Research involving Semax frequently explores cognitive-performance, neurorecovery, focus-related, mental-fatigue, and stress-response research models.

Semax is also commonly investigated alongside compounds such as:

• Selank
• NAD+
• Noopept
• Neurorecovery-focused peptides and nootropic compounds

These combinations are explored for complementary cognitive-performance, neuroprotective, and neuroregulatory signaling pathways.

At BioPeptics, Semax is supplied in sterile lyophilized vial form for enhanced stability and is independently third-party tested for identity and purity verification.

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Research Applications

Cognitive-Performance & Focus Research

Semax is widely researched for its potential interaction with cognitive-performance, attention, and focus-related pathways.

Research models commonly investigate:

• Attention and concentration signaling
• Mental-performance pathways
• Cognitive-endurance research
• Task-engagement and productivity-related signaling
• Mental-fatigue and focus-related models

Memory & Learning Research

Research involving Semax frequently explores its potential interaction with:

• Memory-associated signaling pathways
• Learning and information-processing research
• Neuroplasticity-related mechanisms
• Cognitive-adaptation pathways
• Recall and retention-related studies

Neuroprotective & Neurorecovery Research

Because Semax is researched for its interaction with neurotrophic pathways, experimental models commonly investigate:

• Neuroprotective signaling
• Neuronal-recovery pathways
• Brain-derived neurotrophic factor (BDNF) research
• Recovery-focused neuroscience models
• Neuroplasticity and neural-adaptation signaling

Stress-Response & Neuroendocrine Research

Semax is also commonly researched in models involving:

• Stress-response regulation
• Neuroendocrine signaling pathways
• Mental-fatigue and resilience research
• Cortisol-related stress-response pathways
• Cognitive-performance under stress-related models

Dopaminergic & Neurotransmitter Research

Research involving Semax frequently investigates its potential interaction with:

• Dopaminergic signaling pathways
• Monoamine-related neurotransmitter activity
• Motivation and reward-related signaling
• Cognitive-drive and task-engagement pathways
• Neurochemical-regulation models

Mental-Performance & Productivity Research

Experimental models commonly investigate Semax in:

• Mental-performance and cognitive-endurance studies
• Productivity-focused cognitive models
• Focus-related performance pathways
• High-demand cognitive-performance research
• Cognitive-workload and adaptation studies

Combination Nootropic Research

Semax is frequently researched alongside:

• Selank
• NAD+
• Noopept
• Neurorecovery-focused peptides and nootropic compounds

These combination protocols are commonly investigated for complementary cognitive-performance, neuroprotective, neuroplasticity, and stress-regulation pathways.

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Synergistic Research Applications

Semax is frequently researched alongside complementary nootropic, neuroprotective, and neuroregulatory compounds due to its broad cognitive-performance and neuroplasticity-focused research profile.

In experimental settings, combination protocols are commonly investigated for their potential interaction with:

• Focus-related signaling
• Neuroprotective pathways
• Neurotransmitter modulation
• Stress-response regulation
• Cognitive-endurance pathways
• Neuroplasticity-related signaling

With Selank

One of the most commonly researched combinations involves Semax and Selank.

Semax is commonly investigated for cognitive-performance, focus-related, and neurotrophic signaling pathways, while Selank is researched for stress-response regulation, anxiolytic-related signaling, emotional-regulation signaling, and neuroregulatory pathways.

Research models explore whether this combination may influence:

• Focus and attention-related signaling
• Stress-resilience and cognitive-performance pathways
• Neuroplasticity and neuroprotective signaling
• Mental-fatigue and cognitive-endurance research
• Neurotransmitter-regulation pathways

With NAD+

Semax is also frequently researched alongside NAD+ in cognitive-performance and neurorecovery-focused protocols.

These combinations are investigated for complementary roles involving:

• Cellular-energy and mitochondrial-function pathways
• Mental-performance and cognitive-endurance research
• Neurorecovery signaling
• Stress-response and neuroprotective pathways
• Cognitive-workload adaptation models

With Noopept & Nootropic Research Compounds

Research involving Semax commonly explores combinations with:

• Noopept
• Racetam-related compounds
• Cholinergic-support research compounds
• Neurorecovery-focused peptides

These protocols investigate complementary cognitive-performance, memory-related, and neuroplasticity pathways.

With Neurorecovery & Neuroprotective Research Models

Because Semax is researched for its interaction with BDNF and neuroregulatory pathways, it is often included in broader neuroscience-focused protocols investigating:

• Neuroplasticity and neural-adaptation signaling
• Cognitive-endurance pathways
• Focus-related performance models
• Stress-response regulation
• Neuroprotective and recovery-focused signaling

Neurotrophic Research Profile

Unlike traditional stimulant-based nootropic compounds, Semax is researched for its broader neurotrophic and neuromodulatory signaling profile involving:

• Cognitive-performance pathways
• Neuroplasticity-related signaling
• Neurotransmitter regulation
• Neuroprotective pathways

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Technical Information

Compound Name:
Semax

Chemical Classification:
Synthetic ACTH-Derived Neuroregulatory Peptide

Composition

Semax is a synthetic peptide derived from the ACTH(4–10) fragment of adrenocorticotropic hormone (ACTH), modified to enhance stability and biological resistance during research use.

It is commonly researched for its potential interaction with:

• Cognitive-performance pathways
• Neuroprotective signaling
• Neuroplasticity-related pathways
• Neuroendocrine regulation
• Neurotransmitter-related signaling

Peptide Characteristics

• Synthetic ACTH-derived peptide analogue
• Neuroregulatory and nootropic research peptide
• Commonly researched for cognitive-performance and neuroplasticity pathways
• Investigated for neuroprotective and neurotransmitter-related signaling
• Frequently studied in focus-, memory-, and stress-response research models

Amino Acid Sequence:
Met-Glu-His-Phe-Pro-Gly-Pro

Molecular Formula:
C₃₇H₅₁N₉O₁₀S

Appearance:
White to off-white lyophilized powder

Solubility:
Water soluble

Research Category:
Nootropic and neuroregulatory research peptide

Common Research Areas

• Cognitive-performance and focus-related research
• Memory and learning-associated studies
• Neuroplasticity and neuroprotective pathway investigations
• Stress-response and neuroendocrine research
• Dopaminergic and neurotransmitter-signaling studies
• Mental-performance and cognitive-endurance models

Stability

Semax is typically supplied in lyophilized form to support peptide stability, purity, and long-term storage integrity during laboratory handling and research use.

For Research Purposes Only

Not intended to diagnose, treat, cure, or prevent any disease.

Semax (10mg) — Research Dosage Guidance

Cognitive-Performance Research • Neuroprotective Research • Focus & Stress-Response Research

For Research Use Only

Reconstitution (Mixing)

• Add 2ml bacteriostatic water to the vial
• Inject slowly down the side of the vial
• Allow the peptide to dissolve naturally
• Swirl or roll gently between palms if needed
• Do not shake the vial
• Store reconstituted peptide refrigerated at 2–8°C

Concentration Guide

10mg mixed with 2ml bacteriostatic water provides an approximate concentration of:

• 5mg/ml
• Every 10 insulin units (0.1ml) ≈ 500mcg
• Every 1 insulin unit ≈ 50mcg

Core Research Administration Guidelines

Commonly researched administration ranges include:

• General cognitive-performance research: 250–500mcg daily
• Enhanced focus and stress-response research: 500mcg–1mg daily
• Neurorecovery and intensive neuroprotective research: 1mg twice daily

Commonly Researched Administration Methods

• Subcutaneous administration

Administration Considerations

• Maintain consistent administration timing when appropriate
• Rotate administration sites regularly
• Utilize sterile handling practices

Research Note

Intranasal administration is commonly discussed in literature; however, BioPeptics supplies the injectable format for consistency, stability, and controlled dosing in research settings.

Syringe Measurement Guide

Targeted Research Protocols

1. Daily Cognitive-Performance & Mental-Clarity Research

(Focus, productivity, and cognitive-endurance models)

• Research amount: 250–500mcg
• Frequency: Once daily
• Common timing: Morning or early afternoon
• Typical duration: 10–14 days

Research Notes

Commonly researched in routine cognitive-performance and focus-related protocols.

2. Enhanced Focus & Stress-Response Research

(Executive-function and cognitive-resilience models)

• Research amount: 500mcg–1mg
• Frequency: Once daily
• Common timing: Morning administration
• Typical duration: 10–20 days

Research Notes

Later-day administration may influence alertness-related observations in some research models.

3. Neuroprotective & Neurorecovery Research

(Post-stress and neurorecovery-focused models)

• Research amount: 1mg
• Frequency: Twice daily
• Common timing: Morning and early afternoon
• Typical duration: 10–20 days

Research Notes

Higher-frequency protocols are commonly investigated in intensive neurorecovery-focused research models.

4. Stress-Response & Resilience Research

(Stress-regulation and neuroendocrine-response models)

• Research amount: 250–500mcg
• Frequency: Once daily
• Common timing: Morning
• Typical duration: 10–15 days

Research Notes

Lower-dose protocols are commonly researched in stress-response and resilience-focused models.

5. Maintenance & Intermittent Cognitive-Performance Research

• Research amount: 250mcg
• Frequency: 3–5 days weekly
• Duration: Variable depending on research objectives

Research Notes

Lower-frequency protocols are commonly researched following full cognitive-performance cycles.

Typical Research Cycle Duration

• Typical cycles commonly range from 10–20 days
• Off periods commonly range from 1–2 weeks
• Repeat cycles may vary depending on research objectives

Commonly Investigated Research Areas

• Learning-, memory-, and attention-related pathways
• Neuroprotective and neuroplasticity signaling
• Stress-response and cognitive-endurance research
• Recovery-focused neuroscience and neuroadaptation models
• Neuroregulatory and cognitive-performance research

Important Research Notes

• Utilize sterile single-use administration equipment
• Store reconstituted peptide refrigerated at 2–8°C
• Protect from excessive heat and direct sunlight
• Do not shake after mixing
• Avoid repeated contamination of the vial during handling

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Possible Side Effects

Observed in Research Settings

Semax is generally regarded in research settings as a well-tolerated neuroregulatory peptide with a cognitive-performance and neuroprotective research profile.

Observed responses may vary depending on:

• Research amount
• Administration frequency
• Protocol duration
• Neurochemical sensitivity
• Individual physiological response

Commonly Reported Research Observations

• Mild headaches
• Temporary mental overstimulation or alertness-related observations
• Temporary wakefulness-related changes
• Mild irritability or restlessness
• Light-headedness
• Mild nausea or digestive discomfort
• Administration-site redness or irritation

Cognitive & Neuroregulatory Research Considerations

Because Semax is researched for its interaction with neurotransmitter and neurotrophic pathways, some research settings may observe:

• Temporary changes in mental-performance perception
• Altered focus or concentration-related observations
• Variability in stress-response signaling
• Temporary sleep-pattern disruption following later-day administration
• Increased sensitivity in stimulant-sensitive research models

Dopaminergic & Neurotransmitter Research Considerations

Research involving Semax commonly investigates pathways associated with dopaminergic and monoamine-related signaling.

Some experimental models may observe:

• Motivation-related signaling variations
• Temporary mood-related variability
• Altered cognitive-endurance observations
• Variability in neurochemical response patterns

Administration & Handling Considerations

Improper storage, reconstitution, or administration techniques may increase the likelihood of:

• Administration-site irritation
• Local inflammation
• Reduced peptide stability
• Reduced compound integrity

Additional Research Notes

• Higher research amounts do not necessarily produce proportionally greater effects and may increase the likelihood of side effects
• Individual responses may vary depending on sleep quality, stress levels, concurrent stimulants or nootropics, and overall neurochemical sensitivity
• Combination protocols involving Selank, NAD+, Noopept, or other neuroregulatory compounds may influence overall cognitive and neurochemical response patterns

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Use With Caution in Research Contexts

Because Semax is researched for its interaction with neuroregulatory, neurotrophic, neurotransmitter, and stress-response pathways, research involving complex neurological, mood-related, psychiatric, cardiovascular, or neuroendocrine conditions may warrant additional monitoring and individualized evaluation.

Additional Monitoring May Be Considered In Research Models Involving:

• Anxiety-spectrum or stress-related conditions
• Neurological sensitivity or chronic migraines
• Sleep-related disorders or significant insomnia
• Cardiovascular or cardiometabolic-related conditions
• Dopaminergic or neurotransmitter-related sensitivity
• Seizure-related or neurological-instability research models
• Hormonal or neuroendocrine-related disorders
• Multiple concurrent nootropic, stimulant, or neuroregulatory compounds

Carefully Evaluate Research Models With:

• Known hypersensitivity to peptide compounds
• Severe uncontrolled mood-related, psychiatric, or neurological conditions
• Severe uncontrolled cardiovascular disease
• Active severe systemic illness
• Pregnancy and breastfeeding research contexts

Additional Research Considerations

Because Semax may influence neurotransmitter, neurotrophic, and stress-response signaling pathways, research protocols may warrant monitoring of:

• Sleep-quality and wakefulness-related observations
• Cognitive-performance and focus-related responses
• Stress-response variability
• Mood-related observations
• Overall individual tolerability and neuroregulatory response

Combination protocols involving Selank, NAD+, Noopept, stimulants, or other neuroregulatory compounds may further influence cognitive and neurochemical response patterns.

Important Notice

Semax is supplied strictly as a laboratory research compound and is not approved to diagnose, treat, cure, or prevent any disease.

For Research Use Only

Summary

Semax is a synthetic ACTH-derived neuroregulatory peptide widely researched for its potential interaction with cognitive-performance, neuroprotective, neuroplasticity, neurotransmitter, and stress-response signaling pathways.

Research involving Semax commonly investigates its potential role in:

• Focus-related performance pathways
• Attention and learning-associated signaling
• Memory-related pathways
• Neurorecovery-focused models
• Stress-response regulation
• Neuroendocrine adaptation pathways

Its broad neuroregulatory research profile has contributed to growing research interest across cognitive-performance, neuroscience, and neuroprotective experimental models.

Observed responses in research settings are generally mild and may include:

• Temporary headaches
• Increased alertness-related observations
• Mild irritability
• Temporary wakefulness-related changes
• Mild digestive discomfort
• Administration-site irritation

Responses may vary depending on:

• Research amount
• Protocol duration
• Administration frequency
• Individual neurochemical sensitivity

Because Semax is researched for its interaction with neurotransmitter and neurotrophic pathways, research involving complex neurological, mood-related, psychiatric, or neuroendocrine conditions may warrant additional monitoring and individualized evaluation.

Proper reconstitution, sterile handling practices, consistent administration protocols, and appropriate dosing schedules are important for maintaining peptide stability and minimizing variability during research use.

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.